Cargando…
Inhibition of IL-1β by Aliskiren Improved Renal AQP2 Expression and Urinary Concentration Defect in Ureteral Obstruction and Release
We previously demonstrated that ureteral obstruction is associated with a urinary concentrating defect and reduced expression of renal aquaporins (AQPs), in which the renin–angiotensin system (RAS) may play an important role. The aims of the present study were to examine whether the renin inhibitor...
Autores principales: | Hu, Shan, Xie, Haixia, Luo, Renfei, Feng, Pinning, Liu, Qiaojuan, Han, Mengke, Kong, Yonglun, Zou, Xuenong, Wang, Weidong, Li, Chunling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753185/ https://www.ncbi.nlm.nih.gov/pubmed/31572210 http://dx.doi.org/10.3389/fphys.2019.01157 |
Ejemplares similares
-
Combination of Chymostatin and Aliskiren attenuates ER stress induced by lipid overload in kidney tubular cells
por: Qiu, Miaojuan, et al.
Publicado: (2018) -
Aliskiren Administration during Early Postnatal Life Sex-Specifically Alleviates Hypertension Programmed by Maternal High Fructose Consumption
por: Hsu, Chien-Ning, et al.
Publicado: (2016) -
Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
por: Sureshkumar, Kalathil K
Publicado: (2008) -
Statins ameliorate cholesterol-induced inflammation and improve AQP2 expression by inhibiting NLRP3 activation in the kidney
por: Kong, Yonglun, et al.
Publicado: (2020) -
Reduced urinary release of AQP1‐ and AQP2‐bearing extracellular vesicles in patients with advanced chronic kidney disease
por: Oshikawa‐Hori, Sayaka, et al.
Publicado: (2021)